Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cough-Counting app tested in 616 patients

NCT ID NCT05042063

Knowledge-focused Sponsor: Clinica Universidad de Navarra, Universidad de Navarra Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a smartphone app called Hyfe Cough Tracker to see if it can accurately count coughs in people with lung conditions like COPD, asthma, or COVID-19. Researchers compared the app's cough counts to patients' own reports and expert listening. The goal was to improve how doctors monitor and manage cough-related diseases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

616 people

The number who actually took part.

Started

Sep 2021

Finished

Sep 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

For the main study group, the population are patients with respiratory disease treated in the Clínica Universidad de Navarra (Pamplona and Madrid campuses). Since the validation sub-study 1 only requires elicited sounds, a group of participants from a previous study will be directly invited to participate. For the validation sub-study 2, participants will include both, inpatients admitted to the Clínica Universidad de Navarra and presenting cough, and healthy individuals directly invited to participate by the study team.

Ages

5 to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For participants in the main study group * Outpatient or inpatients at the Clinical Universidad de Navarra with a complaint of cough. * The patient or his/her legal representative, have given consent to participate in the study. For participants in the sub-study groups: * Being 18 years or older. * Providing consent for the sub-study Exclusion Criteria: * Inability to accept the privacy policy and terms of use of Hyfe. * Lack of access to a Wi-Fi network at the site of residence (for the main study group). * Unwillingness to regularly use the cough-surveillance system throughout the monitoring period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma chronic obstructive pulmonary disease COPD, severe early onset Cough COVID-19 gastroesophageal reflux disease pulmonary non-tuberculous mycobacterial infection tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma COPD Cough COVID-19 pneumonia GERD Non-tuberculous mycobacterial pneumonia Tuberculosis

Contacts and locations

Locations

  • Clinica Universidad de Navarra

    Pamplona, Navarre, 31008, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.